Professor, Medicine, University of Mississippi School of Medicine
Internal Medicine
Dr. Marion R. Wofford, MD
|
|
Give Review
Marion R. Wofford, MD works in the field of Internal Medicine. He went to medical school at University of Mississippi School of Medicine. He received awards:"Regional Top Doctor". Marion Wofford is also published. He has 38 publications published. The lastest publication: "Presenting characteristics of trisomy 8 as the primary cytogenetic abnormality associated with childhood acute lymphoblastic leukemia. A Pediatric Oncology Group (POG)...' Dr. Marion R. Wofford accepts all Medicare patients.
Publications
- Effect on institutional revenue of clinical pharmacy services in an ambulatory care clinic.
- Analysis of safety from a human clinical trial with pterostilbene.
- Pharmacologic therapy for nonalcoholic Fatty liver disease in adults.
- Effect of soybean protein on novel cardiovascular disease risk factors: a randomized controlled trial.
- Evaluation of blood pressure measurement and agreement in an academic health sciences center.
- Hypertension in Postmenopausal Women.
- Effect of dietary protein supplementation on blood pressure: a randomized, controlled trial.
- Socioeconomic Position Is Positively Associated With Blood Pressure Dipping Among African-American Adults: The Jackson Heart Study.
- Improving influenza vaccination rates by targeting individuals not seeking early seasonal vaccination.
- Hypertension: issues in control and resistance.
- Racial and ethnic differences in hypertension.
- The treatment of hypertension in obese patients.
- Prevalence, awareness, treatment, and control of hypertension in the Jackson Heart Study.
- Hepatocellular necrosis associated with labetalol.
- Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study.
- A Katrina experience: lessons learned.
- Drug-induced metabolic syndrome.
- Exercise, insulin resistance, and hypertension: a complex relationship.
- The natural treatment of hypertension.
- Relationship between antihypertensive drugs and metabolic syndrome.
- Does it matter how we lower blood pressure?
- Cognitive impairment associated with atorvastatin and simvastatin.
- Mechanisms of obesity-associated cardiovascular and renal disease.
- Ethnicity and unprovoked hypokalemia in the Atherosclerosis Risk in Communities Study.
- Secondary Hypertension: Detection and Management for the Primary Care Provider.
- Obesity Hypertension in the Atherosclerosis Risk in Communities Cohort: Implications of Obesity Guidelines.
- Presenting characteristics of trisomy 8 as the primary cytogenetic abnormality associated with childhood acute lymphoblastic leukemia. A Pediatric Oncology Group (POG)...
- Exercise echocardiography in the detection of anthracycline cardiotoxicity.
- Antihypertensive efficacy of candesartan in comparison to losartan: the CLAIM study.
- Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study.
- Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure.
- Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.
- Does socioeconomic status affect blood pressure goal achievement?
- Antihypertensive effect of alpha- and beta-adrenergic blockade in obese and lean hypertensive subjects.
- The effect of weight loss intervention on antihypertensive medication requirements in the hypertension Optimal Treatment (HOT) study.
- Therapeutic considerations in the treatment of obesity hypertension.
- Pathophysiology and treatment of obesity hypertension.
Schools
University Of Mississippi School Of Medicine
University Miss
Doctors Specialties
- Internal Medicine
Accepted Insurances
- Choice Plus POS II
- American Republic
- Assurant Health
- Blue Card PPO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- GEHA
- Choice Care PPO
- Mail Handlers Benefit Plan (MHBP)
- Medicaid
- Medicare MCR
- State Farm
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Universal American
Awards
- Regional Top Doctor
Education
-
University of Mississippi Medical Center -
University of Mississippi School of Medicine
Drug Facts
| NPI NUMBER | 1720013428 | |
| NPPES Provider LastName | WOFFORD | |
| NPPES Provider FirstName | MARION | |
| NPPES Provider ZIPCode | 392164500 | |
| NPPES Provider State | MS | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 5574.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 129.0 | |
| Percent Opioid Claims | 2.31 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1720013428 |
| Last Name Of The Provider | WOFFORD |
| First Name Of The Provider | MARION |
| View All |
Similar Doctors
|
|
Dr. Derek T. Hansen, MD |
|
|
Dr. Adam D. Isbell, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James D. Pollard, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lewis W. Aldred, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan Isaac, MD |
|
|
Dr. Katreece Ellis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Geeta G. Gyamlani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan P. Hayes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel W. Jones, MD |